COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study
Federico Montini(Mayo Clinic), Massimo Filippi(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Alessandra Mandelli(American Heart Association), Agostino Nozzolillo(IRCCS Ospedale San Raffaele), Paola M. V. Rancoita(Vita-Salute San Raffaele University), Chiara Zanetta(IRCCS Ospedale San Raffaele), Roberto Furlan(Vita-Salute San Raffaele University), Damiano Mistri(Vita-Salute San Raffaele University), Nicolò Tedone(Vita-Salute San Raffaele University), Maria A. Rocca(Vita-Salute San Raffaele University), Lucia Moiola(Vita-Salute San Raffaele University)
Cited by 23
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k